SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-04-001583
Filing Date
2004-06-17
Accepted
2004-06-17 16:45:58
Documents
3
Group Members
ORBIMED ADVISORS LLCORBIMED CAPITAL LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G - ORBIMED CAPITAL LLC sc13g_061704-transkaryotic.txt SC 13G 8668
2 JOINT FILING AGREEMENT ex1-1_061704transkaryotic.txt EX-1.1 1971
3 STATEMENT OF CONTROL PERSON ex2-1_061704transkaryotic.txt EX-2.1 748
  Complete submission text file 0000947871-04-001583.txt   13636
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Subject) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-47221 | Film No.: 04869174
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 767 THIRD AVENUE NEW YORK NY 10017
Business Address 767 THIRD AVENUE NEW YORK NY 10017 2127396400
ORBIMED CAPITAL LLC (Filed by) CIK: 0001157524 (see all company filings)

IRS No.: 134133323 | State of Incorp.: DE | Fiscal Year End: 1231